218 related articles for article (PubMed ID: 36688672)
1. Serine/Threonine Phosphatase Calcineurin Orchestrates the Intrinsic Resistance to Micafungin in the Human-Pathogenic Fungus Mucor circinelloides.
Garcia A; Huh EY; Lee SC
Antimicrob Agents Chemother; 2023 Feb; 67(2):e0068622. PubMed ID: 36688672
[TBL] [Abstract][Full Text] [Related]
2. A Novel Resistance Pathway for Calcineurin Inhibitors in the Human-Pathogenic Mucorales Mucor circinelloides.
Vellanki S; Billmyre RB; Lorenzen A; Campbell M; Turner B; Huh EY; Heitman J; Lee SC
mBio; 2020 Jan; 11(1):. PubMed ID: 31992620
[TBL] [Abstract][Full Text] [Related]
3. Drug-Resistant Epimutants Exhibit Organ-Specific Stability and Induction during Murine Infections Caused by the Human Fungal Pathogen Mucor circinelloides.
Chang Z; Heitman J
mBio; 2019 Nov; 10(6):. PubMed ID: 31690679
[TBL] [Abstract][Full Text] [Related]
4. Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
Gebremariam T; Wiederhold NP; Alqarihi A; Uppuluri P; Azie N; Edwards JE; Ibrahim AS
J Antimicrob Chemother; 2017 Feb; 72(2):462-466. PubMed ID: 27798213
[TBL] [Abstract][Full Text] [Related]
5. Echinocandin antifungal drugs in fungal infections: a comparison.
Chen SC; Slavin MA; Sorrell TC
Drugs; 2011 Jan; 71(1):11-41. PubMed ID: 21175238
[TBL] [Abstract][Full Text] [Related]
6. Leveraging Fungal and Human Calcineurin-Inhibitor Structures, Biophysical Data, and Dynamics To Design Selective and Nonimmunosuppressive FK506 Analogs.
Gobeil SM; Bobay BG; Juvvadi PR; Cole DC; Heitman J; Steinbach WJ; Venters RA; Spicer LD
mBio; 2021 Dec; 12(6):e0300021. PubMed ID: 34809463
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin orchestrates dimorphic transitions, antifungal drug responses and host-pathogen interactions of the pathogenic mucoralean fungus Mucor circinelloides.
Lee SC; Li A; Calo S; Inoue M; Tonthat NK; Bain JM; Louw J; Shinohara ML; Erwig LP; Schumacher MA; Ko DC; Heitman J
Mol Microbiol; 2015 Sep; 97(5):844-65. PubMed ID: 26010100
[TBL] [Abstract][Full Text] [Related]
8. In vitro interaction of caspofungin and immunosuppressives against agents of mucormycosis.
Thakur M; Revankar SG
J Antimicrob Chemother; 2011 Oct; 66(10):2312-4. PubMed ID: 21795260
[TBL] [Abstract][Full Text] [Related]
9. Role of FKS Gene in the Susceptibility of Pathogenic Fungi to Echinocandins.
Hori Y; Shibuya K
Med Mycol J; 2018; 59(2):E31-E40. PubMed ID: 29848909
[TBL] [Abstract][Full Text] [Related]
10. Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus.
Satish S; Jiménez-Ortigosa C; Zhao Y; Lee MH; Dolgov E; Krüger T; Park S; Denning DW; Kniemeyer O; Brakhage AA; Perlin DS
mBio; 2019 Jun; 10(3):. PubMed ID: 31164462
[No Abstract] [Full Text] [Related]
11. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Fera MT; La Camera E; De Sarro A
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
[TBL] [Abstract][Full Text] [Related]
12. Breakthrough invasive candidiasis in patients on micafungin.
Pfeiffer CD; Garcia-Effron G; Zaas AK; Perfect JR; Perlin DS; Alexander BD
J Clin Microbiol; 2010 Jul; 48(7):2373-80. PubMed ID: 20421445
[TBL] [Abstract][Full Text] [Related]
13. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
Al-Baqsami ZF; Ahmad S; Khan Z
Sci Rep; 2020 Apr; 10(1):6238. PubMed ID: 32277126
[TBL] [Abstract][Full Text] [Related]
14. Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin.
Singh SD; Robbins N; Zaas AK; Schell WA; Perfect JR; Cowen LE
PLoS Pathog; 2009 Jul; 5(7):e1000532. PubMed ID: 19649312
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression.
Niimi K; Woods MA; Maki K; Nakayama H; Hatakenaka K; Chibana H; Ikeda F; Ueno K; Niimi M; Cannon RD; Monk BC
J Antimicrob Chemother; 2012 Jul; 67(7):1666-76. PubMed ID: 22514266
[TBL] [Abstract][Full Text] [Related]
16. Heterotrimeric G-alpha subunits Gpa11 and Gpa12 define a transduction pathway that control spore size and virulence in Mucor circinelloides.
Patiño-Medina JA; Reyes-Mares NY; Valle-Maldonado MI; Jácome-Galarza IE; Pérez-Arques C; Nuñez-Anita RE; Campos-García J; Anaya-Martínez V; Ortiz-Alvarado R; Ramírez-Díaz MI; Chan Lee S; Garre V; Meza-Carmen V
PLoS One; 2019; 14(12):e0226682. PubMed ID: 31887194
[TBL] [Abstract][Full Text] [Related]
17. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.
Beyda ND; Lewis RE; Garey KW
Ann Pharmacother; 2012; 46(7-8):1086-96. PubMed ID: 22811350
[TBL] [Abstract][Full Text] [Related]
18. Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations.
Desnos-Ollivier M; Bretagne S; Lortholary O; Dromer F;
Antimicrob Agents Chemother; 2022 May; 66(5):e0172521. PubMed ID: 35412354
[TBL] [Abstract][Full Text] [Related]
19. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.
Alexander BD; Johnson MD; Pfeiffer CD; Jiménez-Ortigosa C; Catania J; Booker R; Castanheira M; Messer SA; Perlin DS; Pfaller MA
Clin Infect Dis; 2013 Jun; 56(12):1724-32. PubMed ID: 23487382
[TBL] [Abstract][Full Text] [Related]
20. Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations.
Arendrup MC; Perlin DS; Jensen RH; Howard SJ; Goodwin J; Hope W
Antimicrob Agents Chemother; 2012 May; 56(5):2435-42. PubMed ID: 22354305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
